Lena B.
- Country
- Germany
- Department
- University hospital cologne
Research Overview
- Efficacy and Safety of AZD5148 for the Prevention of Recurrent Clostridioides difficile Infection in Adults: A Phase IIb, Randomized, Placebo-Controlled Study
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of VE303 for Recurrent Clostridioides difficile Infection Prevention in Adults
- Phase II Randomized Controlled Trial on Efficacy of Fecal Microbiota Transfer with Colistin Sulfate and Vancomycin in Decolonizing MDR Enterobacteriaceae
Data & Insights
Has run more than one trial at 16 of 102 partner sites.
Specializations
Gastrointestinal Microbiome Research
The investigator specializes in studying and treating microbiome-related infections, with particular emphasis on managing resistant bacterial colonizations in the digestive system.
- Multidrug-resistant Enterobacteriaceae infections
- Fecal microbiota transfer interventions
- Bacterial decolonization strategies
Advanced expertise in developing therapeutic approaches using encapsulated microbiota transfer products.
Infectious Disease Management
Focused on innovative treatments for Clostridioides difficile infections, particularly in cases of recurrent infections requiring specialized intervention.
- Prevention of recurrent infections
- Novel therapeutic approaches
- Treatment optimization strategies
Dedicated to evaluating new therapeutic agents for preventing infection recurrence.
Antimicrobial Resistance
Expertise in addressing multidrug resistance in bacterial infections through innovative therapeutic approaches and personalized treatment strategies.
- Antibiotic resistance management
- Individualized treatment protocols
- Novel decolonization approaches
Specializes in developing targeted interventions for resistant bacterial infections.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.